MediPal Holdings Corporation
MEPDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,438,244 | $945,159,000 | $864,156,000 | $982,500,000 |
| % Growth | -99.3% | 9.4% | -12% | – |
| Cost of Goods Sold | $6,017,556 | $880,481,000 | $802,622,000 | $914,716,000 |
| Gross Profit | $420,688 | $64,678,000 | $61,534,000 | $67,784,000 |
| % Margin | 6.5% | 6.8% | 7.1% | 6.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $41,075,000 | $42,151,000 | $40,206,000 |
| SG&A Expenses | $346,132 | $47,267,000 | $47,898,000 | $46,194,000 |
| Sales & Mktg Exp. | $0 | $6,192,000 | $5,747,000 | $5,988,000 |
| Other Operating Expenses | $0 | $3,358,000 | $3,399,000 | $3,380,000 |
| Operating Expenses | $346,132 | $50,625,000 | $51,297,000 | $49,574,000 |
| Operating Income | $74,556 | $14,053,000 | $10,237,000 | $18,210,000 |
| % Margin | 1.2% | 1.5% | 1.2% | 1.9% |
| Other Income/Exp. Net | $68,371 | $4,612,000 | $553,000 | $7,958,000 |
| Pre-Tax Income | $142,927 | $18,665,000 | $10,790,000 | $26,168,000 |
| Tax Expense | $42,392 | $6,054,000 | $4,488,000 | $8,510,000 |
| Net Income | $84,527 | $9,586,000 | $4,041,000 | $14,511,000 |
| % Margin | 1.3% | 1% | 0.5% | 1.5% |
| EPS | 0.41 | 46.17 | 19.43 | 69.78 |
| % Growth | -99.1% | 137.6% | -72.2% | – |
| EPS Diluted | 0.41 | 46.17 | 19.43 | 69.78 |
| Weighted Avg Shares Out | 206,236 | 207,628 | 207,960 | 207,947 |
| Weighted Avg Shares Out Dil | 206,236 | 207,628 | 207,960 | 207,947 |
| Supplemental Information | – | – | – | – |
| Interest Income | $595 | $913,000 | $804,000 | $757,000 |
| Interest Expense | $20 | $0 | $0 | $0 |
| Depreciation & Amortization | $31,231 | $3,353,000 | $4,604,250 | $4,495,500 |
| EBITDA | $174,198 | $17,411,000 | $14,837,250 | $22,706,500 |
| % Margin | 2.7% | 1.8% | 1.7% | 2.3% |